Clinical perspectives of podiatrists in the care of patients with chemotherapy-induced neuropathy

Neuropathy is a common condition among cancer patients receiving neurotoxic chemotherapy. It is associated with symptoms such as tingling, prickling and muscle weakness, particularly in the hands and feet. Neuropathy can also lead to problems with gait and balance, and an increased risk of falling. The podiatrist could play an important role in the treatment of patients with chemotherapy-induced neuropathy. However, we do not know what the current clinical perspectives of Dutch podiatrists are, nor whether they have specific needs (such as training or guidelines) to be able to provide adequate care.

A mixed-methods study is being conducted involving focus groups and a survey amongst Dutch podiatrists

All the data for this study has been collected and the analyses have been carried out. Work is currently underway on the research report.

Podiatry, neuropathy, chemotherapy, cancer

Collaborating partners: Researchers from the Antoni van Leeuwenhoek Hospital and Amsterdam UMC

Funding bodies: Rondom Podotherapeuten